ArticleHaematologica2021

Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers.

Thomas Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.